Anat Loewenstein, MD, MHA, explores dual Ang-2/VEGF-A inhibition in the management of diabetic macular edema and exudative age-related macular degeneration.
Rapid Readout: Angiopoietin-2 (Ang2) Inhibition in the Treatment of Diabetic Macular Edema and Exudative AMD.
Angiogenesis, Exudation, and Degeneration 2021 Virtual Symposium highlights and thoughts on current treatments options for DME and exudative AMD are discussed.
Advertisement
Advertisement
Trending on Modern Retina
1
Current and Emerging Treatments for Geographic Atrophy and When to Initiate Therapy
2
AAO 2025: Subretinal drusenoid deposits in Black and Hispanic patients with AMD
3
FDA approves Glaukos’ Epioxa incision-free keratoconus therapy
4
